The Valley Desk

Healthcare research from Johnson & Johnson, page 9

A filtered view. Show the full list.

Refine

817 publications and 7 software projects · listings 193–216

Listings

  1. Clinical trial reportInflammatory bowel diseases

    Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  2. Clinical trial reportThe international journal of neuropsychopharmacology

    Safety, tolerability, and preliminary efficacy of seltorexant versus quetiapine extended release as adjunctive therapy in major depressive disorder: a randomized, flexible-dose, 6-month, parallel-group, exploratory study

    Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, Philadelphia VA Medical Center, University of Pennsylvania. Affiliation source

    Clinical careAdded

  3. Clinical trial reportThe international journal of neuropsychopharmacology

    Weight and metabolic changes in patients with schizophrenia treated with paliperidone palmitate 6-month formulation versus paliperidone palmitate 3-month formulation: a post-hoc analysis

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  4. ArticleJournal of the American Medical Informatics Association : JAMIA

    Med.ai ASK: an agentic system for biomedical question answering

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Research dataAdded

  5. ArticleJournal of the American Medical Informatics Association : JAMIA

    REWARD-an open-source framework for identifying the unknown benefits of existing medications to inform drug discovery, development, and repurposing

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Research dataAdded

  6. ArticleJapanese journal of clinical oncology

    Japanese subgroup analysis of AQUILA trial: daratumumab vs active monitoring in high-risk smoldering multiple myeloma

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  7. ArticleThe oncologist

    Incidence and outcomes of FGFR inhibitor-associated retinopathy of patients treated with oral erdafitinib across the clinical trial program

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  8. ArticleThe oncologist

    Biomarker testing patterns among patients newly diagnosed with metastatic non-small cell lung cancer, prostate cancer, and bladder cancer

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  9. ArticleRheumatology (Oxford, England)

    Prediction of foetal atrioventricular conduction using maternal disease, treatment and anti-Ro/La autoantibody levels

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  10. ArticleSkin health and disease

    Guselkumab treatment of psoriasis results in sustained reduction of systemic inflammatory biomarkers to week 48 in three phase III randomized controlled trials

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  11. ArticleToxicological sciences : an official journal of the Society of Toxicology

    Safetyome and specialized panels for over 3,000 phenotypes: a systematic and translational approach using human genetics and pharmacology

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Research dataAdded

  12. ArticleThe Journal of dermatology

    Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  13. ArticleBioethics

    The Changing Application of Vulnerability Across the Different Phases of Clinical Research

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Biomedical and life sciencesAdded

  14. ReviewClinical and translational science

    Esketamine Nasal Spray: Mechanism of Action, Clinical, and Translational Science

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  15. ArticleDiabetes, obesity & metabolism

    Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network Study

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  16. Clinical trial reportEuropean journal of neurology

    Evaluation of Sustained Disease Control With Nipocalimab Versus Placebo in the Phase 3 Vivacity-MG3 Study

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  17. LetterJournal of the European Academy of Dermatology and Venereology : JEADV

    Caution is needed for systematic reviews and interpretation of preference studies

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  18. Clinical trial reportJournal of the European Academy of Dermatology and Venereology : JEADV

    Durability of response to icotrokinra for high-impact site psoriasis: 1-year ICONIC-TOTAL findings

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  19. ArticleScience (New York, N.Y.)

    Couple-close: Unified approach to semisaturated cyclic scaffolds

    Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Princeton University. Affiliation source

    Other scienceAdded

  20. ArticleArchives of disease in childhood. Fetal and neonatal edition

    Paediatric outcomes after maternal nipocalimab for haemolytic disease of the fetus and newborn: an open-label, single-arm study

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  21. ArticleBMJ open

    Lack of association between the brain penetrance of calcium channel blockers and the incidence of neuropsychiatric outcomes: a retrospective, multidatabase cohort study

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Public healthAdded

  22. ArticleBMJ open

    Associations between achieving treatment targets and functional and economic outcomes in patients with rheumatoid arthritis: retrospective cohort analyses of BRASS registry data

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  23. ArticleBMJ open

    Efficacy and safety of long-acting injectable paliperidone palmitate 1-month and 3-month formulations in the maintenance treatment of schizophrenia: a single-arm, open-label, interventional study in Rwandan healthcare settings

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  24. ArticleLupus science & medicine

    Baseline characteristics of patients with SLE with and without lupus nephritis from the Latin American multiethnic GLADEL 2.0 cohort

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded